Periodontitis Support Protocol
Primary Stack
Core supplements with strongest evidenceSupports immune function and bone health; deficiency linked to periodontitis severity
Supporting Studies (1)
Supports gum tissue health; topical and oral forms studied
Supporting Studies (1)
Supporting Stack
Additional supplements for enhanced resultsAnti-inflammatory; may reduce gum inflammation
Supporting Studies (1)
Essential for collagen synthesis and gum tissue health
Supporting Studies (1)
Oral probiotics may reduce pathogenic bacteria and inflammation
Supporting Studies (1)
How This Protocol Works
Simple Explanation
Periodontitis is a serious gum infection that damages the soft tissue and bone supporting your teeth. Without treatment, it can lead to tooth loss.
PROGRESSION:
SYMPTOMS:
RISK FACTORS:
TREATMENT:
PREVENTION:
* CoQ10 supports gum tissue health.
* Omega-3s reduce inflammation.
* Professional care is essential.
Expected timeline: Inflammation reduces within weeks of treatment. Bone preservation requires ongoing care. Supplements support but don't replace dental treatment.
Clinical Perspective
Periodontitis: Inflammatory disease affecting periodontal tissues; leads to attachment loss, bone destruction. Microbiome dysbiosis (P. gingivalis, A. actinomycetemcomitans). Systemic links: cardiovascular disease, diabetes, adverse pregnancy outcomes.
Treatment: Non-surgical (scaling and root planing) first-line. Adjunctive local/systemic antibiotics in select cases. Surgery for persistent pockets. Smoking cessation critical. Supplements: CoQ10 has best evidence; vitamin D deficiency common; omega-3 reduces inflammation. Supplements adjunctive to professional care.
* Vitamin D (B-grade): Immune/bone. Systematic review: (PMID: 28750270). 2000-4000 IU daily.
* CoQ10 (B-grade): Gum tissue. Meta-analysis: (PMID: 26132992). 100-200mg daily.
* Omega-3 (B-grade): Anti-inflammatory. Systematic review: (PMID: 27840029). 2-3g EPA+DHA daily.
* Vitamin C (B-grade): Collagen synthesis. Review: (PMID: 23440782). 500-1000mg daily.
* Probiotics (C-grade): Oral microbiome. Systematic review: (PMID: 24045160). L. reuteri lozenges.
Protocol notes: Risk assessment: smoking most modifiable risk factor. Diabetes: bidirectional relationship; control glycemia. Maintenance: 3-4 month recalls essential for stability. Systemic health: treat periodontitis to improve diabetes control, reduce CV risk. Pregnancy: associated with preterm birth; treat active disease. Host modulation: subantimicrobial doxycycline option. Regenerative: bone grafts, guided tissue regeneration for select defects.